Physicochemical Properties
| Molecular Formula | C12H26O13 |
| Molecular Weight | 378.3270 |
| Exact Mass | 378.137 |
| CAS # | 6138-23-4 |
| Related CAS # | D-(+)-Trehalose;99-20-7 |
| PubChem CID | 181978 |
| Appearance | White to off-white solid powder |
| Density | 1.76 g/cm3 |
| Boiling Point | 675.4ºC at 760 mmHg |
| Melting Point | 97-99 °C(lit.) |
| Flash Point | 362.3ºC |
| Index of Refraction | 181 ° (C=7, H2O) |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 25 |
| Complexity | 348 |
| Defined Atom Stereocenter Count | 10 |
| SMILES | C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O.O.O |
| InChi Key | DPVHGFAJLZWDOC-PVXXTIHASA-N |
| InChi Code | InChI=1S/C12H22O11.2H2O/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12;;/h3-20H,1-2H2;2*1H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-;;/m1../s1 |
| Chemical Name | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol;dihydrate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Trehalose dihydrate is a harmless natural disaccharide that is used as a food additive and medicinal excipient [1].. |
| References |
[1]. Amorphous trehalose dihydrate by cryogenic milling. Carbohydr Res. 2011 Jun 1;346(8):1061-4. |
Solubility Data
| Solubility (In Vitro) | H2O : ~150 mg/mL (~396.48 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (132.16 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6432 mL | 13.2160 mL | 26.4320 mL | |
| 5 mM | 0.5286 mL | 2.6432 mL | 5.2864 mL | |
| 10 mM | 0.2643 mL | 1.3216 mL | 2.6432 mL |